214
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis and Antiproliferative Activity of Novel 2-Substituted N-Methylated Benzimidazoles and Tetracyclic Benzimidazo [1,2-a]Quinolines

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 343-354 | Received 20 Jul 2017, Accepted 14 Jan 2018, Published online: 09 Mar 2018
 

ABSTRACT

In this paper, the synthesis, antiproliferative activity in vitro and structure–activity relationship of N-methylated 2-benzimidazoles related to 2,3-acrylonitriles and benzimidazo [1,2-a]quinolines bearing halogeno or amino substituent is described. Amino-substituted N-methylated benzimidazo[1,2-a]quinolines were prepared by using microwave-assisted amination from corresponding halogeno-substituted precursors. All newly prepared compounds were tested against tree human cancer cells to assess their antiproliferative activity in vitro. Compounds 4a and 4b display certain selective activity against MCF-7 cells together with the N,N-dimethylamino-substituted derivative 4e with IC50 0.4 µM. Cyclic derivatives 7a, 7b, and 8 were more active with IC50 in micromolar range of concentrations but without any selectivity among tested cells. Among the most active compounds, 2-amino-substituted derivatives 9a and 9b were also selective against HCT116 cells with IC50 values 0.2 µM and 0.4 µM, respectively. The influence of compounds 9a and 9b on the cell cycle of HCT 116 revealed that both compounds induced a strong reduction of the percentage of cells in S phase, along with the induction of cell death.

Additional information

Funding

This work has been supported by the Croatian Science Foundation under the projects 5596 (Synthesis and cytostatic evaluations of novel nitrogen heterocycles library) and 5660 (A multi-disciplinary approach to discover selective drugs targeting cancer stem cells: The role of potassium transport – Multi-CaST).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.